Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Lewis

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Scandinavian Journal of Haematology|January 1, 1971
Erythropoiesis stimulating factorsJ P Lewis, D A Alford, W A Neal, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1971
The selective inactivation of an ESF-generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1971
The selective membrane filtration of an erythropoiesis-stimulating factor (ESF)--generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1971
The selective membrane filtration of an ESF-generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
The Annals of Thoracic Surgery|March 27, 2001
The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory supportS M Mehta, W E Pae, G Rosenberg, et al.
Nature Communications|April 26, 2020
Marine resource abundance drove pre-agricultural population increase in Stone Age ScandinaviaJ P Lewis, D B Ryves, P Rasmussen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, D S Goldstein, et al.
Nature Communications|May 20, 2022
Reply to "Marine abundance and its prehistoric past in the Baltic"J P Lewis, D B Ryves, P Rasmussen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
The CYP2C19*17 variant is not independently associated with clopidogrel responseJ P Lewis, S H Stephens, R B Horenstein, et al.
Genomics|July 8, 2008
Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1J L Bento, N D Palmer, M Zhong, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Scandinavian Journal of Haematology|January 1, 1971
Erythropoiesis stimulating factorsJ P Lewis, D A Alford, W A Neal, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1971
The selective inactivation of an ESF-generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1971
The selective membrane filtration of an erythropoiesis-stimulating factor (ESF)--generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1971
The selective membrane filtration of an ESF-generating factor (EGF) in the presence of erythropoietin (ESF)J P Lewis, E T Welch, W A Neal, et al.
The Annals of Thoracic Surgery|March 27, 2001
The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory supportS M Mehta, W E Pae, G Rosenberg, et al.
Nature Communications|April 26, 2020
Marine resource abundance drove pre-agricultural population increase in Stone Age ScandinaviaJ P Lewis, D B Ryves, P Rasmussen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, D S Goldstein, et al.
Nature Communications|May 20, 2022
Reply to "Marine abundance and its prehistoric past in the Baltic"J P Lewis, D B Ryves, P Rasmussen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
The CYP2C19*17 variant is not independently associated with clopidogrel responseJ P Lewis, S H Stephens, R B Horenstein, et al.
Genomics|July 8, 2008
Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1J L Bento, N D Palmer, M Zhong, et al.
Pageof 13